India’s pharmaceutical sector is currently experiencing an unprecedented rise, presenting fantastic opportunities for aspiring innovators. Fueled by a combination of factors—including increasing healthcare expenditure, a growing geriatric segment, and a robust government emphasis on ‘Make in India’—the landscape is ripe for disruption and